Upgrade to SI Premium - Free Trial

JPMorgan Reiterates Neutral Rating on Emerson (EMR)

November 5, 2024 8:23 AM
JPMorgan analyst C. Stephen Tusa Jr. reiterated a Neutral rating and $135.00 price target on Emerson (NYSE: EMR).The analyst comments ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments

Next Articles